Tabuk Pharmaceuticals Manufacturing Company develops, manufactures, markets and distributes branded generic pharmaceuticals and under-licensed products globally. Established in 1994 in Saudi Arabia, Tabuk Pharmaceuticals’ fast growth has allowed it to become a global company, with a strong focus on the Middle East and North Africa region. Today, Tabuk Pharmaceuticals is present in over 20 markets and employs approximately 1,500 employees. Tabuk Pharmaceuticals operates in multiple therapeutic areas including CNS, cardiovascular, anti-infectives, respiratory, and muscular skeletal system.
Tabuk Pharmaceuticals’ distinctive marketing capabilities, state of the art manufacturing facilities, broad product portfolio, deep understanding of pharmaceutical regulations, and strong partnerships and affiliations, helped create a leading pharmaceutical player in the MENA region. Its standing as one of the largest Arab pharmaceutical companies, and the first Saudi Pharmaceutical Company to obtain EU-GMP certification, is a tribute to competencies and know-how.
Tabuk Pharmaceuticals’ aim is to consistently exceed the demands of our patients by providing them with the best quality drugs at affordable prices.
Tabuk Pharmaceuticals is a fully owned subsidiary of Astra Industrial Group (AIG), a publicly traded company on the Saudi stock exchange.
For more information, click here.